Journey Medical Corp Share Price

NASDAQ: DERM

Small Cap

$7.12

+0.01

(+0.14%)

as on September 16, 2025 at 1:29 am IST

$₹

Journey Medical Corp Stock Performance

as on September 16, 2025 at 1:29 am IST

Day's Low
Day's High
$7
Day's Price Range
$7.21
$7.12
1.69%
Downside
1.26%
Upside
52 Week's Low
52 Week's High
$3.54
52-Week Price Range
$8.9
$7.12
50.35%
Downside
25.00%
Upside

Journey Medical Corp share price movements today

Previous Close: $7.11
Open: $7.07
Volume: 450.8K
Day's Low - High: $7 - $7.21
52 Week Low - High: $3.54 - $8.9

Journey Medical Corp Historical Returns

1 Month Return: + 2.3 %
3 Month Return: + 4.87 %
1 Year Return: + 37.79 %
3 Year Return: + 120.81 %
5 Year Return: 0 %

Journey Medical Corp Stock Fundamentals & Key Indicators

Check Journey Medical Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$187.1M

EPS (TTM)

-0.316

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

91.02

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-2.9M

Revenue (TTM)

56.4M

Profit Margin

-15.49%

Return On Equity TTM

486381800.00%

Journey Medical Corp Stock Valuation

Track how Journey Medical Corp P/E has moved over time to understand its valuation trends.

Journey Medical Corp in the last 5 years

Overview
Trends

Lowest (0.00x)

September 15, 2025

Industry (0.00x)

September 15, 2025

Today (91.02x)

September 15, 2025

Highest (-0.79x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 91.02x

Journey Medical Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Journey Medical Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Journey Medical Corp	BUY	$187.1M	NA	91.02	-15.49%
United Therapeutics Corporation	BUY	$18.3B	NA	15.8	40.36%
Haleon Plc Spon Ads	BUY	$44.1B	NA	21.8	13.81%
Neurocrine Biosciences Inc.	BUY	$14.1B	36.02%	41.97	13.88%
Zoetis Inc.	BUY	$65.7B	-8.68%	25.51	27.83%

Stock Returns calculator for Journey Medical Corp Stock including INR - Dollar returns

The Journey Medical Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Journey Medical Corp investment value today

Current value as on today

₹1,42,970

Returns

₹42,970

(+42.97%)

Returns from Journey Medical Corp Stock

₹37,984 (+37.98%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Journey Medical Corp Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Journey Medical Corp. Average target price of $11.8

Journey Medical Corp Share Price Target

Get share price movements and forecasts by analysts on Journey Medical Corp.

What analysts predicted

39.66%UPSIDE

Target Price

$11.8

Current Price

$7.12

Analyzed by

9 Analysts

Target

$11.80

Journey Medical Corp target price $11.8, a slight upside of 39.66% compared to current price of $7.12. According to 9 analysts rating.

Journey Medical Corp Stock's Interest Amongst Investors

Search interest for Journey Medical Corp Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:25% versus previous 30 day period

Journey Medical Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	12	17	34	15	13	14	14	13	13	15
Gross Profit	5	9	28	9	6	8	9	11	8	9
Operating Income	-9	-7	17	-2	-10	-2	-2	2	-3	-2
EBITDA	-8	-6	17	-1	-9	-1	0	3	-2	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	1	0	0	0	0	0	1	1	1
Income Before Tax	-10	-8	16	-2	-10	-3	-2	1	-4	-3
Income Tax Expense	0	-2	0	0	0	-	-	0	-	0
Net Income	-10	-8	16	-2	-10	-3	-2	1	-4	-3
Net Profit Margin	-82.99%	-48.70%	48.61%	-14.05%	-80.14%	-22.63%	-16.34%	11.17%	-31.00%	-25.29%

Journey Medical Corp Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	7	22	4	42	34	44	63	73	79	56
Gross Profit	7	22	4	41	24	29	31	42	52	35
Operating Income	-79	-90	-300	-213	5	7	-25	-27	-2	-13
EBITDA	-78	-87	-294	-205	6	9	-32	-23	1	-8
Interest Expense	0	1	8	15	0	0	7	2	1	2
Depreciation	-	-	-	-	0	0	2	4	4	3
Income Before Tax	-79	-89	-303	-221	5	7	-42	-29	-3	-14
Income Tax Expense	0	3	5	0	1	1	1	0	0	0
Net Income	-78	-89	-303	-221	3	5	-43	-29	-3	-14
Net Profit Margin	-1073.96%	-394.44%	-6678.29%	-523.25%	10.38%	11.86%	-69.68%	-40.22%	-4.87%	-26.14%

Journey Medical Corp Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	16	-2	-10	-3	-2	1	-4	-3
Operating Cash Flow	3	18	-16	-5	-5	-1	2	-2	0
Investing Cash Flow	-	-	5	-	-	-	-15	-	-
Financing Cash Flow	-13	-10	19	1	5	0	10	3	0
Change in Cash	-9	7	2	-3	0	-1	-2	0	0

Journey Medical Corp Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-89	-303	-221	3	5	-43	-29	-3	-14
Operating Cash Flow	-74	-103	-213	9	5	-2	-13	5	-9
Investing Cash Flow	-130	-104	-13	-2	-1	-10	-20	-5	-15
Financing Cash Flow	138	462	35	-3	0	53	16	-4	16
Change in Cash	-65	254	-190	3	3	40	-17	-4	-7

Global Institutional Holdings in Journey Medical Corp

Funds	Holdings
TANG CAPITAL MANAGEMENT LLC	7.96%
Wasatch Advisors LP	3.99%
Vanguard Group Inc	1.6%
Renaissance Technologies Corp	1.02%
American Financial Group Inc	0.77%

See all

Insights on Journey Medical Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, DERM has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DERM has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, DERM stock has moved up by 120.8%
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -4.07M → -3.79M (in $), with an average increase of 7.3% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 13.13M → 15.00M (in $), with an average increase of 12.5% per quarter

About Journey Medical Corp

Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.

Organisation	Journey Medical Corp
Headquarters	9237 East Via de Ventura Boulevard, Scottsdale, AZ, United States, 85258
Industry	Health Technology
CEO	Mr. Claude Maraoui
E-voting on shares	Click here to vote

Key Management of Journey Medical Corp

Name	Title
Dr. Lindsay Allan Rosenwald M.D.	Executive Chairman
Mr. Claude Maraoui	Founder, President, CEO & Director
Mr. Joseph M. Benesch	CFO & Corporate Controller
Mr. Ramsey Alloush	COO, General Counsel & Company Secretary
Mr. Robert Nevin	Chief Commercial Officer
Jaclyn Jaffe	Senior Director of Corporate Operations
Mr. Louis Donati	Director of Market Access

FAQs

What is Journey Medical Corp share price today?

Journey Medical Corp share price today is $7.12 as on September 16, 2025 at 1:29 am IST at the close of the market. Journey Medical Corp share today touched a day high of $7.21 and a low of $7.

What is the 52 week high and 52 week low for Journey Medical Corp share?

Journey Medical Corp share touched a 52 week high of $8.9 on August 12, 2025 and a 52 week low of $3.54 on January 22, 2025. Journey Medical Corp stock price today i.e. September 16, 2025 at 1:29 am IST is closed at $7.12,which is 20.00% down from its 52 week high and 101.41% up from its 52 week low.

What is Journey Medical Corp's market capitalisation today?

Journey Medical Corp market capitalisation is $0.00T as on September 16, 2025 at 1:29 am IST.

How to invest in Journey Medical Corp Stock (DERM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Journey Medical Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Journey Medical Corp Shares that will get you 0.2107 shares as per Journey Medical Corp share price of $7.12 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Journey Medical Corp Stock (DERM) from India?

Indian investors can start investing in Journey Medical Corp (DERM) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 3:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Journey Medical Corp stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 3:37 am IST). Based on Journey Medical Corp share’s latest price of $7.12 as on September 16, 2025 at 1:29 am IST, you will get 1.4045 shares of Journey Medical Corp. Learn more about fractional shares .